
Anthropic aims for up to $64bn raise in $1.3tn Nasdaq debut
Anthropic, the maker of the Claude chatbot, plans to float on the Nasdaq this month with a target…

A four‑year immersive bioscience and biotherapeutics (iBio) programme at the University of Limerick will now include a founding industry residency partner, Irish biotech firm Nuritas.
The iBio programme, which integrates a bachelor’s and master’s degree, will award graduates a master’s qualification and up to two years of paid experience in the biopharma sector, working on real scientific challenges.
Nuritas, headquartered in Dublin and specialising in AI‑driven discovery of bioactive peptides, will have access to the first cohort of iBio students and the academic staff shaping the curriculum.
Dr Nora Khaldi, founder and CEO of Nuritas, said the partnership aligns with the programme’s innovative mindset and offers an opportunity to equip scientific talent across Ireland with skills to translate research into impact.
Prof Jakki Cooney, co‑founder of the iBio course, added that industry insight is central to the programme’s ambition to reimagine how students learn the science of medicine‑making and discovery.
Source: Silicon Republic. Photo: Ludovic Delot / Pexels.